Resistant Tuberculosis Drug Sirturo (bedaquiline) Approved By FDA

Sirturo (bedaquiline) has been approved by the FDA as part of combination therapy for adults with multi-drug resistant tuberculosis when other alternatives are not possible. This is the first TB medication to be approved in four decades, the FDA informed. The Food and Drug Administration (FDA) says that Sirturo has been approved for use with older medications for a very hard-to-treat TB strain that has not responded properly to other drugs. The agency added that Sirturo should be prescribed with caution because it carried risks of potentially lethal heart problems...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/uBk5JXNAxaQ/254507.php

sport sport medical sport news